Cytosolic Aspartate Availability Determines Cell Survival When Glutamine Is Limiting.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 30122555.
- Also identified by DOI 10.1016/j.cmet.2018.07.021 and PMC identifier 6390946.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Mitochondrial function is important for aspartate biosynthesis in proliferating cells. Here, we show that mitochondrial aspartate export via the aspartate-glutamate carrier 1 (AGC1) supports cell proliferation and cellular redox homeostasis. Insufficient cytosolic aspartate delivery leads to cell death when TCA cycle carbon is reduced following glutamine withdrawal and/or glutaminase inhibition. Moreover, loss of AGC1 reduces allograft tumor growth that is further compromised by treatment with the glutaminase inhibitor CB-839. Together, these findings argue that mitochondrial aspartate export sustains cell survival in low-glutamine environments and AGC1 inhibition can synergize with glutaminase inhibition to limit tumor growth.
Medical subject headings
- Amino Acid Transport Systems, Acidic
- Antiporters
- Aspartic Acid
- Cell Survival
- Cytosol
- Glutamine